title: Characterization of a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase from the mitochondrial outer membrane as a protein distinct from the malonyl-CoA-insensitive carnitine palmitoyltransferase of the inner membrane.
abstract: By using octyl glucoside in the presence of glycerol, it is possible to obtain a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) from the outer membranes of rat liver mitochondria. H.p.l.c. on hydroxyapatite column has now allowed a clear separation of the CPTo from the malonyl-CoA-insensitive CPT activity of the inner membranes (CPTi). The separated CPTo activity showed inhibition by low micromolar concentrations of malonyl-CoA, 2-tetradecylglycidyl-CoA and etomoxir-CoA. On solubilization and fractionation, the CPTo rapidly lost activity, unlike the relatively stable CPTi activity. Reconstitution into asolectin liposomes enhanced the activity and the malonyl-CoA-sensitivity of the CPTo fractions, whereas it had no such effect on the activity or malonyl-CoA insensitivity of the CPTi fractions. A polyclonal antibody raised against the malonyl-CoA-insensitive enzyme, purified from the inner membranes, precipitated the CPTi activity, but showed no reactivity with the CPTo fractions. In Western blots, the above antibody did not react with any polypeptide of the CPTo fractions. Incubation of the outer-membrane preparations with [3H]etomoxir, in the presence of ATP and CoA, led to labelling of a 90 kDa polypeptide that in the above hydroxyapatite chromatography was eluted in the same region as the CPTo. No such polypeptide labelling was seen in the CPTi fractions. With heart and skeletal-muscle mitochondria, the correspondingly labelled polypeptide was of about 86 kDa. These results show that the CPTo and CPTi are distinct proteins, that a subunit of 90 kDa for liver and 86 kDa for muscle constitutes a component of their respective CPTo systems, and that the 66 kDa subunit of the CPTi does not constitute a part of the CPTo system.
authors.affiliation: Laboratory of Intermediary Metabolism, Clinical Research Institute of Montreal, Quebec, Canada.
authors.forename: M S
authors.initials: MS
authors.lastname: Murthy
authors.forename: S V
authors.initials: SV
authors.lastname: Pande
mesh_terms: D000214:Acyl Coenzyme A; D000217:Acyltransferases / Q000378:metabolism*; D000818:Animals; D001384:Azetidines; D002334:Carnitine O-Palmitoyltransferase / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004852:Epoxy Compounds / Q000494:pharmacology; D007425:Intracellular Membranes / Q000201:enzymology*; D008316:Malonyl Coenzyme A / Q000494:pharmacology; D008565:Membrane Proteins / Q000302:isolation & purification / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000201:enzymology* / Q000648:ultrastructure; D010171:Palmitoyl Coenzyme A / Q000494:pharmacology; D051381:Rats; D012995:Solubility
chemical_list: D000214:Acyl Coenzyme A; D001384:Azetidines; D004852:Epoxy Compounds; D008565:Membrane Proteins; D010171:Palmitoyl Coenzyme A; D008316:Malonyl Coenzyme A; C042420:2-tetradecylglycidyl-coenzyme A; D000217:Acyltransferases; D002334:Carnitine O-Palmitoyltransferase; C054207:etomoxir